FDA Inspection
ISORX CYCLOTRON CENTERISORX CYCLOTRON CENTER – FDA Inspection, Mar 20, 2025
Record Details
This FDA Inspection record concerns ISORX CYCLOTRON CENTER, with an inspection on March 20, 2025, issued by the Dallas District Office, covering human drugs.
View Company Profile
ID · acb95493-b2ab-4b18-a36c-ed6168464e55
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1264258
- FDA center
- Human Drugs
- Project area
- Generic Drug Evaluation
FDA Citations
6- 21 CFR 212.110(b)Record quality
- 21 CFR 212.20(e)Written QA procedures established, followed
- 21 CFR 212.30(a)Orderly handling, prevention of mix-ups, prevention of contamination
- 21 CFR 212.30(b)Equipment procedures
- 21 CFR 212.50Adequate controls (general)
- 21 CFR 212.60(g)Test records complete (general)
Full citation text and observation details available on the Dashboard.
Other FDA inspections of ISORX CYCLOTRON CENTER
1| Date | Classification | Office | Project area |
|---|---|---|---|
| March 13, 2026 | Not classified | Dallas District Office | Generic Drug Evaluation |
Other documents for ISORX CYCLOTRON CENTER
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.